SB Technology (ID)【VGLS】銘柄情報

SB Technology Holdings Inc (ID) (VGLS) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.41

( -8.89% )

買値

0.0119

売値

0.61

出来高

2,272

0.41 日の範囲 0.4101

0.000001 52 週間の範囲 2.00

時価総額

432.457k

前日終値

0.45

始値

0.41

時刻

0.41

最終取引時間

財務取引量

US$ 932

VWAP

0.41

平均取引量 (3 か月)

US$ 13,532

発行済株式数

1,054,774

配当利回り

PER

1 株当たり利益 (EPS)

歳入

純利益

-4.3M

SB Technology Holdings Inc. does not have significant operations. Previously, the company was engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. SB Technology Holdings Inc. was incorporated in 1995 and is based in New York, New York. SB Technology ... SB Technology Holdings Inc. does not have significant operations. Previously, the company was engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. SB Technology Holdings Inc. was incorporated in 1995 and is based in New York, New York. SB Technology Holdings Inc. operates as a subsidiary of KH Feelux Co., Ltd. 詳細を表示

セクター

Real Estate

業界

Real Estate

ウェブサイト

www.vglscorp.com

本社

New York, United States

設立

1995

SB Technology Holdings Inc (ID) is listed in the Real Estate sector of the その他OTC with ticker VGLS. The last closing price for SB Technology (ID) was US$0.45. Over the last year, SB Technology (ID) shares have traded in a share price range of US$ 0.000001 to US$ 2.00.

SB Technology (ID) currently has 1,054,774 shares in issue. The market capitalisation of SB Technology (ID) is US$432,457.34 .

Form 10-12G - Registration of securities [Section 12(g)]

VG Life Sciences Granted Combination Cancer Drug Patent

VG Life Sciences Granted Combination Cancer Drug Patent U.S. Patent Covers Group of Compounds Combined With Existing Treatments To Fight...

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015 PR Newswire SANTA BARBARA, Calif., June 16, 2015 SANTA...

VG Life Sciences Granted Key Composition Of Matter Patent

VG Life Sciences Granted Key Composition Of Matter Patent U.S. Patent Covers Synthetic Peptide That Displaces Ectopic CLIP in Chronic...

VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.

SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded...

Q1 2014 Shareholder Update Letter

SANTA BARBARA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences Inc. releases a Q1 2014 Shareholder...

VG Life Sciences Inc. Moves to Restore Financial Accountability & Completes Prior Year Audits, Plans to File Form 10

SANTA BARBARA, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences (VGLS) is a publically traded...

VG Life Sciences, Inc.'s Reports on Clinical Outcomes in Phase I Cancer Study

SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology...

VG Life Sciences, Inc. Increases Authorized Shares

SANTA BARBARA, Calif., Jan. 3, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTC Pink: VGLS) a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.23	-35.9375	0.64	0.65	0.39	5098	0.58505983	CS
4	-0.34	-45.3333333333	0.75	0.9	0.39	5565	0.51250924	CS
12	0.4099	409900	0.0001	2	5.0E-5	1860814	0.00152024	CS
26	0.409999	40999900	1.0E-6	2	1.0E-6	7077463	0.00022923	CS
52	0.40995	819900	5.0E-5	2	1.0E-6	4960175	0.00017897	CS
156	0.4099	409900	0.0001	2	1.0E-6	7629189	0.00010523	CS
260	0.4055	9011.11111111	0.0045	2	1.0E-6	45515144	0.00054374	CS